Vir Biotechnology Inc (NAS:VIR)
$ 10.09 -0.63 (-5.87%) Market Cap: 1.37 Bil Enterprise Value: 431.23 Mil PE Ratio: 0 PB Ratio: 0.89 GF Score: 57/100

Vir Biotechnology Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 18, 2023 / 07:00PM GMT
Release Date Price: $25 (-0.08%)
Joey Stringer
Needham & Company, LLC - Moderator

Good afternoon, everyone. Thank you for joining the 22nd Annual Needham Healthcare Conference. My name is Joey Stringer, and I'm one of the biotech analysts at Needham & Company. It's my pleasure to introduce our next presenting company Vir Biotechnology. Joining us today from Vir CFO, Sung Lee; and CMO, Phil Pang.

For those of you joining on the webcast, if you want to ask a question, you can do so at any time. You can submit a question using the chat box feature at the bottom of your screen. So with that we'll get started. Sung and Phil, thanks so much for joining us today.

Sung Lee
Vir Biotechnology, Inc. - CFO

Yeah. Thanks, Joey, for hosting us.

Questions & Answers

Joey Stringer
Needham & Company, LLC - Moderator

Great. So high level -- Vir recently had some management changes bringing in a new CEO, Marianne Backer and some -- you also recently joined the company. What attracted you to Vir? And secondly, is there any change in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot